Filing Details
- Accession Number:
- 0001209191-19-061976
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-26 17:02:08
- Reporting Period:
- 2019-12-20
- Accepted Time:
- 2019-12-26 17:02:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 860730 | Hca Healthcare Inc. | HCA | Services-General Medical & Surgical Hospitals, Nec (8062) | 273865930 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1551011 | Martin P. Paslick | One Park Plaza Nashville TN 37203 | Svp And Cio | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-08-01 | 6,406 | $0.00 | 0 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2019-08-01 | 6,406 | $0.00 | 127,999 | No | 5 | G | Indirect | By Spouse |
| Common Stock | Acquisiton | 2019-12-20 | 10,175 | $47.97 | 10,175 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-20 | 6,011 | $147.53 | 4,164 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2019-12-24 | 4,164 | $148.56 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 5 | G | Indirect | By Spouse |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Right | Disposition | 2019-12-20 | 10,175 | $0.00 | 10,175 | $47.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,200 | 2024-02-05 | No | 4 | M | Direct |
Footnotes
- The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.
Billionaire Hedge Funds
